Morningstar Investor users sign in here.

Company Profile

  • Business description

    BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.

  • Contact

    Queen Victoria Building
    GPO Box Q128
    Sydney NSW 1230
    AUS

    https://www.bcaldiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2024

    Employees

Stocks News & Analysis

stocks

3 undervalued US value shares with moats

Value continues to underperforming but it may be a function of how we think about the investing style.  
stocks

Undervalued energy producer reports earnings

Guidance creditably maintained despite cyclones. 
stocks

Undervalued bank reports earnings

Shares jump but the operating environment remains difficult and we lower our fair value. 

Markets

Index
Last price
Change
% Change
All Ordinaries 7,898.90 37.90 0.48%
CAC 40 8,023.26 41.75 0.52%
DAX 40 17,837.40 67.38 0.38%
Dow JONES (US) 37,775.38 22.07 0.06%
FTSE 100 7,877.05 29.06 0.37%
HKSE 16,385.87 134.03 0.82%
NASDAQ 15,601.50 81.87 -0.52%
Nikkei 225 38,079.70 117.90 0.31%
NZX 50 Index 11,836.04 39.31 -0.33%
S&P 500 5,011.12 11.09 -0.22%
S&P/ASX 200 7,642.10 36.50 0.48%
SSE Composite Index 3,074.22 2.84 0.09%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.03 0.00 -2.86%
Imugene Ltd IMU 0.08 0.01 -6.02%
Myer Holdings Ltd MYR 0.72 0.01 1.41%
Telstra Group Ltd TLS 3.67 0.01 -0.27%
The Star Entertainment Group Ltd SGR 0.42 0.01 1.20%
Pantoro Ltd PNR 0.09 0.01 6.10%
Zip Co Ltd ZIP 1.14 0.04 -2.98%
South32 Ltd S32 3.29 0.04 1.23%
Pilbara Minerals Ltd PLS 3.92 0.08 2.08%
EML Payments Ltd EML 1.00 0.00 0.00%